Clinical Decision Support Systems Market by Component (Services  Software)  Delivery Mode  Product  Application  Model (Knowledge-based)  Type (Therapeutic  Diagnostic)  Interactivity (Active  Passive)  Patient Care Setting - Global Forecasts to 2023

Clinical Decision Support Systems Market by Component (Services Software) Delivery Mode Product Application Model (Knowledge-based) Type (Therapeutic Diagnostic) Interactivity (Active Passive) Patient Care Setting - Global Forecasts to 2023

MarketsandMarkets | ID: 1524180418602 | Published at: 2018-03-16 | Pages: 201

  • €4.785,63


“Clinical decision support systems market is projected to grow at a CAGR of 11.8%.”
The clinical decision support systems market is expected to reach USD 1,752.0 million by 2023 from USD 1,001.9 million in 2018, at a CAGR of 11.8%. Growth in the market is primarily driven by the government support and initiatives to drive adoption of HCIT solutions in healthcare, rising incidence of medication errors, rising prominence and usage of big data and mhealth tools, growing adoption of cloud computing in healthcare and partnerships between medical research groups & clinical decision support companies. However, reluctance to adopt mobile CDSS, high investments for IT infrastructure, data security concerns related to cloud-based CDSS, and lack of interoperability is likely to restrain the market to certain extent.

“Conventional CDSS to dominate the market, by application in 2017” On the basis of application, the market has been segmented into conventional and advanced CDSS. In 2017, the conventional CDSS segment commanded the largest share of the global CDSS market. However, the advanced CDSS segment is estimated to grow at the highest rate in the forecast period. This is owing to these systems performing additional functions such as population health management, financial decision support, assisting clinicians in real-time evidence-based decision making, treatment planning, and protocol validation.

“Integrated CDSS segment is projected to grow at the highest CAGR during the forecast period.”
Based on product, the clinical decision support systems (CDSS) market is segmented into integrated CDSS and standalone CDSS. Of these, the integrated CDSS segment accounted for the largest market share in 2017. The large share of this segment is majorly attributed to the growing deployments of integrated CDSS. Integrated CDSS are widely used by healthcare providers as they improve the quality of care and health outcomes and reduce medication errors. While using integrated solutions, users can easily switch from one type of application to another without exiting the program.

“Asia Pacific to witness the highest growth during the forecast period.”
Geographically, North America is expected to account for the largest share of the global clinical decision support systems market in 2017, followed by Europe, Asia Pacific, and the Rest of the World (RoW). However, Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2018–2023. Factors such as the presence of a large patient population demanding better healthcare at lower costs, economic growth, implementation of favorable government policies, increasing spending on IT infrastructure by healthcare providers, and growing focus of various market players on emerging Asian countries are driving the growth of the market in this region.
Break of primary participants was as mentioned below:
 By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
 By Designation: Director Level: 39%, C-Level: 29%, Others: 32%
 By Region: North America: 32%, Europe: 24%, APAC: 26%, RoW: 18%

The report includes the study of key players offering clinical decision support systems such as Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation Inc. (US), Medical Information Technology, Inc. (US), Philips Healthcare (Netherlands), Allscripts Healthcare Solutions, Inc. (US), Wolters Kluwer Health (US), Hearst Health (US), Elsevier B.V. (Netherlands), and International Business Machines (IBM) Corporation (US).

Research Coverage:
The report segments the global clinical decision support systems market on the basis of component, delivery mode, product, type, model, level of interactivity, application, settings, and region, with analysis and forecasts to 2023. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the solutions offered by top players in the clinical decision support systems market. The report analyzes the clinical decision support systems market, by component, delivery mode, product, type, model, user interactivity, settings, and application
• Product Development/Innovation: Detailed insights on research and development activities and product launches in the clinical decision support systems market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the clinical decision support systems market across regions
• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the clinical decision support systems market
• Competitive Assessment: In-depth assessment of strategies, products, and distribution networks of the leading players in the clinical decision support systems market

TABLE OF CONTENTS

1 INTRODUCTION 17

  • 1.1 OBJECTIVES OF THE STUDY 17
  • 1.2 MARKET DEFINITION 17
  • 1.3 MARKET SCOPE 18
    • 1.3.1 MARKETS COVERED 18
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY 19
  • 1.4 CURRENCY 19
  • 1.5 LIMITATIONS 19
  • 1.6 STAKEHOLDERS 20
    2 RESEARCH METHODOLOGY 21
  • 2.1 RESEARCH DATA 21
    • 2.1.1 SECONDARY DATA 22
      • 2.1.1.1 Secondary sources 23
    • 2.1.2 PRIMARY DATA 24
      • 2.1.2.1 Key data from primary sources 25
      • 2.1.2.2 Breakdown of primaries 25
      • 2.1.2.3 Key industry insights 26
  • 2.2 MARKET SIZE ESTIMATION 26
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
  • 2.4 ASSUMPTIONS FOR THE STUDY 29
    3 EXECUTIVE SUMMARY 30
    4 PREMIUM INSIGHTS 37
  • 4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW 37
  • 4.2 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL (2018 VS. 2023) 38
  • 4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY
    (2018 VS. 2023) 38
  • 4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION (2018 VS. 2023) 39
  • 4.5 GEOGRAPHIC SNAPSHOT OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET 40
    5 MARKET OVERVIEW 41
  • 5.1 INTRODUCTION 41
  • 5.2 MARKET DYNAMICS 41
    • 5.2.1 MARKET DRIVERS 42
      • 5.2.1.1 Government support and initiatives 42
      • 5.2.1.2 High prevalence of chronic diseases 43
      • 5.2.1.3 Growing incidence of medication errors 44
      • 5.2.1.4 Rising prominence and usage of big data and mHealth tools 44
      • 5.2.1.5 High returns on investment for cdss solutions 45
      • 5.2.1.6 Growing adoption of cloud computing in healthcare 45
      • 5.2.1.7 Partnerships between medical research groups and clinical decision support companies 46
      • 5.2.1.8 Rapid growth in the geriatric population 46
    • 5.2.2 RESTRAINTS 47
      • 5.2.2.1 Reluctance to adopt mobile CDSS 47
      • 5.2.2.2 High investments for IT infrastructure 47
      • 5.2.2.3 Data Security concerns related to cloud-based CDSS 48
      • 5.2.2.4 Lack of interoperability 48
    • 5.2.3 MARKET OPPORTUNITIES 49
      • 5.2.3.1 Emerging markets for healthcare IT 49
      • 5.2.3.2 Technological advancements in healthcare IT solutions 50
    • 5.2.4 MARKET CHALLENGES 50
      • 5.2.4.1 Integration of CDSS solutions within healthcare organizations 50
      • 5.2.4.2 Lack of skilled IT professionals in the healthcare industry 51
    • 5.2.5 US REGULATORY LANDSCAPE: CLINICAL DECISION SUPPORT SYSTEMS 51
      • 5.2.5.1 Clinical decision support systems and meaningful use requirements 52
        6 CASE STUDIES 54
  • 6.1 INTRODUCTION 54
  • 6.2 DEPLOYMENT OF CDSS RESULTED IN THE EARLY DETECTION OF HIV PATIENTS 54
  • 6.3 IMPLEMENTATION OF CLOUD-BASED DECISION SUPPORT PLATFORM HELPED REDUCE SEPSIS MORTALITY RATE 54
  • 6.4 REDUCTION IN THE NUMBER OF UNNECESSARY LABORATORY TESTS AT THE INDIANA BRANCH OF THE VETERANS HEALTH ADMINISTRATION AFTER USING A CLINICAL DECISION SUPPORT TOOL 55
  • 6.5 USE OF CLINICAL DECISION SUPPORT TOOL HELPED REDUCE DIAGNOSTIC ERRORS 55
    7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT 56
  • 7.1 INTRODUCTION 57
  • 7.2 SERVICES 58
  • 7.3 SOFTWARE 59
  • 7.4 HARDWARE 60
    8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT 62
  • 8.1 INTRODUCTION 63
  • 8.2 INTEGRATED CDSS 64
  • 8.3 STANDALONE CDSS 66

9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE 67

  • 9.1 INTRODUCTION 68
  • 9.2 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS 69
  • 9.3 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS 70
    10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL 71
  • 10.1 INTRODUCTION 72
  • 10.2 KNOWLEDGE-BASED CDSS 73
  • 10.3 NON-KNOWLEDGE-BASED CDSS 74
    11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE 76
  • 11.1 INTRODUCTION 77
  • 11.2 ON-PREMISE CDSS 78
  • 11.3 CLOUD-BASED CDSS 79
    12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION 80
  • 12.1 INTRODUCTION 81
  • 12.2 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS 82
  • 12.3 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS 83
    13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY 84
  • 13.1 INTRODUCTION 85
  • 13.2 ACTIVE CDSS 86
  • 13.3 PASSIVE CDSS 87
    14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING 88
  • 14.1 INTRODUCTION 89
  • 14.2 INPATIENT SETTINGS 90
  • 14.3 AMBULATORY CARE SETTINGS 91
    15 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION 92
  • 15.1 INTRODUCTION 93
  • 15.2 NORTH AMERICA 95
    • 15.2.1 US 99
    • 15.2.2 CANADA 104
  • 15.3 EUROPE 109
    • 15.3.1 GERMANY 114
    • 15.3.2 UK 118
    • 15.3.3 FRANCE 122
    • 15.3.4 ROE 126
  • 15.4 ASIA PACIFIC 131
  • 15.5 ROW 139
    16 COMPETITIVE LANDSCAPE 146
  • 16.1 OVERVIEW 146
  • 16.2 RANKING OF PLAYERS AND INDUSTRY CONCENTRATION, 2017 147
  • 16.3 COMPETITIVE SCENARIO 148
    • 16.3.1 PRODUCT DEPLOYMENTS, ENHANCEMENTS, AND INTEGRATIONS 148
    • 16.3.2 PRODUCT LAUNCHES 148
    • 16.3.3 AGREEMENTS, PARTNERSHIPS, CONTRACTS, AND COLLABORATIONS 149
    • 16.3.4 ACQUISITIONS 150
    • 16.3.5 EXPANSIONS 150
      17 COMPANY PROFILES 151
      (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
  • 17.1 CERNER 151
  • 17.2 MCKESSON 156
  • 17.3 EPIC SYSTEMS 159
  • 17.4 MEDITECH 161
  • 17.5 PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS ELECTRONICS) 164
  • 17.6 WOLTERS KLUWER HEALTH 168
  • 17.7 HEARST HEALTH 171
  • 17.8 ELSEVIER B.V. (A DIVISION OF RELX GROUP) 175
  • 17.9 IBM 179
  • 17.10 ALLSCRIPTS HEALTHCARE SOLUTIONS 183

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
18 APPENDIX 189

  • 18.1 DISCUSSION GUIDE 189
  • 18.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 194
  • 18.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 196
  • 18.4 AVAILABLE CUSTOMIZATIONS 197
  • 18.5 RELATED REPORTS 198
  • 18.6 AUTHOR DETAILS 199

LIST OF TABLES

TABLE 1 GLOBAL POPULATION STATISTICS, 2015 VS. 2030 VS. 2050 (MILLION INDIVIDUALS) 47
TABLE 2 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 57
TABLE 3 CLINICAL DECISION SUPPORT SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 59
TABLE 4 CLINICAL DECISION SUPPORT SOFTWARE MARKET, BY REGION,
2016–2023 (USD MILLION) 60
TABLE 5 CLINICAL DECISION SUPPORT HARDWARE MARKET, BY REGION,
2016–2023 (USD MILLION) 61
TABLE 6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT,
2016–2023(USD MILLION) 63
TABLE 7 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023(USD MILLION) 65
TABLE 8 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023(USD MILLION) 66
TABLE 9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE,
2016–2023 (USD MILLION) 68
TABLE 10 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023 (USD MILLION) 69
TABLE 11 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023 (USD MILLION) 70
TABLE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL,
2016–2023 (USD MILLION) 72
TABLE 13 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023 (USD MILLION) 74
TABLE 14 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023 (USD MILLION) 75
TABLE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE,
2016–2023 (USD MILLION) 77
TABLE 16 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023 (USD MILLION) 78
TABLE 17 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023 (USD MILLION) 79
TABLE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 81
TABLE 19 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023 (USD MILLION) 82
TABLE 20 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023 (USD MILLION) 83
TABLE 21 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016–2023 (USD MILLION) 85
TABLE 22 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023 (USD MILLION) 86
TABLE 23 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY REGION, 2016–2023 (USD MILLION) 87
TABLE 24 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING,
2016–2023 (USD MILLION) 89
TABLE 25 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS,
BY REGION, 2016–2023 (USD MILLION) 90
TABLE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2016–2023 (USD MILLION) 91
TABLE 27 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION,
2016–2023 (USD MILLION) 94
TABLE 28 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY COUNTRY, 2016–20213 (USD MILLION) 96
TABLE 29 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY COMPONENT, 2016–2023 (USD MILLION) 96
TABLE 30 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY DELIVERY MODE, 2016–2023 (USD MILLION) 96
TABLE 31 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY PRODUCT, 2016–2023 (USD MILLION) 97
TABLE 32 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 97
TABLE 33 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY MODEL, 2016–2023 (USD MILLION) 98
TABLE 34 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY LEVEL OF INTERACTIVITY, 2016–2023 (USD MILLION) 98
TABLE 35 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 98
TABLE 36 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY SETTING, 2016–2023 (USD MILLION) 99
TABLE 37 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 101
TABLE 38 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE,
2016–2023 (USD MILLION) 102
TABLE 39 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 102
TABLE 40 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE,
2016–2023 (USD MILLION) 102
TABLE 41 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL,
2016–2023 (USD MILLION) 103
TABLE 42 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016–2023 (USD MILLION) 103
TABLE 43 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 104
TABLE 44 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING,
2016–2023 (USD MILLION) 104
TABLE 45 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016–2023 (USD MILLION) 105
TABLE 46 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016–2023 (USD MILLION) 105
TABLE 47 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 106
TABLE 48 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE,
2016–2023 (USD MILLION) 106
TABLE 49 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL,
2016–2023 (USD MILLION) 107
TABLE 50 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY LEVEL OF INTERACTIVITY, 2016–2023 (USD MILLION) 107
TABLE 51 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 108
TABLE 52 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY SETTING, 2016–2023 (USD MILLION) 108
TABLE 53 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 110
TABLE 54 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY COMPONENT, 2016–2023 (USD MILLION) 110
TABLE 55 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY DELIVERY MODE, 2016–2023 (USD MILLION) 111
TABLE 56 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY PRODUCT, 2016–2023 (USD MILLION) 111
TABLE 57 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 112
TABLE 58 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY MODEL, 2016–2023 (USD MILLION) 112
TABLE 59 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY LEVEL OF INTERACTIVITY, 2016–2023 (USD MILLION) 112
TABLE 60 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 113
TABLE 61 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY SETTING, 2016–2023 (USD MILLION) 113
TABLE 62 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY COMPONENT, 2016–2023 (USD MILLION) 115
TABLE 63 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY DELIVERY MODE, 2016–2023 (USD MILLION) 115
TABLE 64 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY PRODUCT, 2016–2023 (USD MILLION) 116
TABLE 65 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 116
TABLE 66 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY MODEL, 2016–2023 (USD MILLION) 116
TABLE 67 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY LEVEL OF INTERACTIVITY, 2016–2023 (USD MILLION) 117
TABLE 68 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 117
TABLE 69 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY SETTING, 2016–2023 (USD MILLION) 118
TABLE 70 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 119
TABLE 71 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE,
2016–2023 (USD MILLION) 119
TABLE 72 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 120
TABLE 73 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE,
2016–2023 (USD MILLION) 120
TABLE 74 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL,
2016–2023 (USD MILLION) 121
TABLE 75 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016–2023 USD MILLION) 121
TABLE 76 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 122
TABLE 77 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING,
2016–2023 (USD MILLION) 122
TABLE 78 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY COMPONENT, 2016–2023 (USD MILLION) 123
TABLE 79 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY DELIVERY MODE, 2016–2023 (USD MILLION) 123
TABLE 80 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY PRODUCT, 2016–2023 (USD MILLION) 124
TABLE 81 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 124
TABLE 82 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY MODEL, 2016–2023 (USD MILLION) 124
TABLE 83 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY LEVEL OF INTERACTIVITY, 2016–2023 (USD MILLION) 125
TABLE 84 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 125
TABLE 85 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY SETTING, 2016–2023 (USD MILLION) 126
TABLE 86 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY COMPONENT, 2016–2023 (USD MILLION) 127
TABLE 87 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY DELIVERY MODE, 2016–2023 (USD MILLION) 128
TABLE 88 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY PRODUCT, 2016–2023 (USD MILLION) 128
TABLE 89 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 129
TABLE 90 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY MODEL, 2016–2023 (USD MILLION) 129
TABLE 91 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY LEVEL OF INTERACTIVITY, 2016–2023 (USD MILLION) 129
TABLE 92 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 130
TABLE 93 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY SETTING, 2016–2023 (USD MILLION) 130
TABLE 94 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY COMPONENT, 2016–2023 (USD MILLION) 135
TABLE 95 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY DELIVERY MODE, 2016–2023 (USD MILLION) 136
TABLE 96 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY PRODUCT, 2016–2023 (USD MILLION) 136
TABLE 97 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 137
TABLE 98 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY MODEL, 2016–2023 (USD MILLION) 137
TABLE 99 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY LEVEL OF INTERACTIVITY, 2016–2023 (USD MILLION) 137
TABLE 100 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 138
TABLE 101 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY SETTING, 2016–2023 (USD MILLION) 138
TABLE 102 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY COMPONENT, 2016–2023 (USD MILLION) 142
TABLE 103 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY DELIVERY MODE, 2016–2023 (USD MILLION) 142
TABLE 104 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY PRODUCT, 2016–2023 (USD MILLION) 143
TABLE 105 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 143
TABLE 106 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY MODEL, 2016–2023 (USD MILLION) 144
TABLE 107 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY LEVEL OF INTERACTIVITY, 2016–2023 (USD MILLION) 144
TABLE 108 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 145
TABLE 109 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET,
BY SETTING, 2016–2023 (USD MILLION) 145
TABLE 110 WOLTERS KLUWER LED THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
IN 2017 147
TABLE 111 PRODUCT DEPLOYMENTS (2014–2018) 148
TABLE 112 PRODUCT LAUNCHES (2014–2018) 148
TABLE 113 AGREEMENTS, PARTNERSHIPS, CONTRACTS, AND COLLABORATIONS
(2014–2018) 149
TABLE 114 ACQUISITIONS (2014–2018) 150


LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY: GLOBAL CDSS MARKET 21
FIGURE 2 RESEARCH DESIGN 22
FIGURE 3 SAMPLING FRAME: PRIMARY RESEARCH 24
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 27
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 27
FIGURE 6 DATA TRIANGULATION METHODOLOGY 28
FIGURE 7 THE SERVICES SEGMENT DOMINATED THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, IN 2017 30
FIGURE 8 ON-PREMISE CDSS ACCOUNTED FOR THE LARGER SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, IN 2017 31
FIGURE 9 INTEGRATED CDSS TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, IN 2018 31
FIGURE 10 CONVENTIONAL CDSS TO CONTINUE TO DOMINATE THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, IN 2023 32
FIGURE 11 KNOWLEDGE-BASED CDSS ACCOUNTED FOR THE LARGEST SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, IN 2017 33
FIGURE 12 ACTIVE CDSS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET,
BY LEVEL OF INTERACTIVITY, DURING THE FORECAST PERIOD 33
FIGURE 13 THERAPEUTIC CDSS COMMANDED THE LARGER SHARE OF THE MARKET,
BY TYPE, IN 2017 34
FIGURE 14 INPATIENT SETTINGS TO DOMINATE THE CDSS MARKET, BY SETTING, DURING THE FORECAST PERIOD 35
FIGURE 15 ASIA PACIFIC TO WITNESS THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD 36
FIGURE 16 GOVERNMENT INITIATIVES TO DRIVE THE ADOPTION OF CDSS SOLUTIONS DURING THE FORECAST PERIOD 37
FIGURE 17 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS TO DOMINATE THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, IN 2018 38
FIGURE 18 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS TO DOMINATE THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, IN 2018 38
FIGURE 19 ADVANCED CDSS SEGMENT COMMANDS THE LARGEST SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, IN 2018 39
FIGURE 20 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 40
FIGURE 21 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
FIGURE 29 INPATIENT SETTINGS ACCOUNTED FOR LARGEST SHARE OF THE CDSS MARKET 89
FIGURE 30 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2017 93
FIGURE 31 NORTH AMERICA: MARKET SNAPSHOT 95
FIGURE 32 EUROPE: MARKET SNAPSHOT 109
FIGURE 33 ASIA PACIFIC: MARKET SNAPSHOT 132
FIGURE 34 ROW: MARKET SNAPSHOT 139
FIGURE 35 KEY DEVELOPMENTS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET BETWEEN 2014 AND 2018 146
FIGURE 36 CERNER: COMPANY SNAPSHOT 151
FIGURE 37 MCKESSON: COMPANY SNAPSHOT 156
FIGURE 38 MEDITECH: COMPANY SNAPSHOT 161
FIGURE 39 PHILIPS: COMPANY SNAPSHOT 164
FIGURE 40 WOLTERS KLUWER: COMPANY SNAPSHOT 168
FIGURE 41 RELX GROUP: COMPANY SNAPSHOT 175
FIGURE 42 IBM: COMPANY SNAPSHOT 179
FIGURE 43 ALLSCRIPTS HEALTHCARE SOLUTIONS: COMPANY SNAPSHOT 183

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!